Holdings of iShares U.S. Pharmaceuticals ETF
ISIN US4642888360
iShares Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 1B $ including 999.5M $ in equities, 99.9 %
- Positions
- 56 in 4 countries
- Top ten
- 78.3 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 942,632 | 230.4M $ | 23.03 % |
| 2 | Eli Lilly & Co | 229,087 | 210.7M $ | 21.06 % |
| 3 | Merck & Co Inc | 394,200 | 47.4M $ | 4.74 % |
| 4 | Pfizer Inc | 1,678,022 | 47.1M $ | 4.71 % |
| 5 | Royalty Pharma PLC | 981,152 | 47.1M $ | 4.70 % |
| 6 | Bristol-Myers Squibb Co | 763,754 | 46.3M $ | 4.63 % |
| 7 | Zoetis Inc | 382,419 | 45.2M $ | 4.52 % |
| 8 | Viatris Inc | 3,219,194 | 43.5M $ | 4.35 % |
| 9 | Elanco Animal Health Inc | 1,388,731 | 33.2M $ | 3.32 % |
| 10 | Jazz Pharmaceuticals PLC | 169,838 | 32.1M $ | 3.21 % |
| 11 | Axsome Therapeutics Inc | 118,359 | 20M $ | 2.00 % |
| 12 | Terns Pharmaceuticals Inc | 240,429 | 12.7M $ | 1.27 % |
| 13 | Ligand Pharmaceuticals Inc | 55,011 | 11M $ | 1.10 % |
| 14 | Indivior Pharmaceuticals Inc | 348,967 | 10.6M $ | 1.06 % |
| 15 | Corcept Therapeutics Inc | 261,660 | 10.5M $ | 1.05 % |
| 16 | Crinetics Pharmaceuticals Inc | 286,520 | 10.4M $ | 1.04 % |
| 17 | Supernus Pharmaceuticals Inc | 160,263 | 8.3M $ | 0.83 % |
| 18 | Prestige Consumer Healthcare Inc | 132,257 | 7.8M $ | 0.78 % |
| 19 | Tarsus Pharmaceuticals Inc | 109,154 | 7.7M $ | 0.77 % |
| 20 | Liquidia Corp | 192,090 | 7.2M $ | 0.72 % |
| 21 | Edgewise Therapeutics Inc | 207,131 | 6.5M $ | 0.65 % |
| 22 | Amneal Pharmaceuticals Inc | 474,468 | 5.9M $ | 0.59 % |
| 23 | Nektar Therapeutics | 78,204 | 5.6M $ | 0.56 % |
| 24 | Definium Therapeutics Inc | 275,332 | 5.2M $ | 0.52 % |
| 25 | Alumis Inc | 226,551 | 5M $ | 0.50 % |
| 26 | Enliven Therapeutics Inc | 124,406 | 4.9M $ | 0.49 % |
| 27 | Innoviva Inc | 198,530 | 4.6M $ | 0.46 % |
| 28 | Organon & Co | 726,652 | 4.4M $ | 0.44 % |
| 29 | Perrigo Co PLC | 384,659 | 4.1M $ | 0.41 % |
| 30 | Ocular Therapeutix Inc | 486,759 | 4.1M $ | 0.41 % |
| 31 | ANI Pharmaceuticals Inc | 50,247 | 3.9M $ | 0.39 % |
| 32 | Trevi Therapeutics Inc | 290,306 | 3.5M $ | 0.35 % |
| 33 | Harrow Inc | 92,131 | 3.2M $ | 0.32 % |
| 34 | Amylyx Pharmaceuticals Inc | 233,280 | 3.2M $ | 0.32 % |
| 35 | Phibro Animal Health Corp | 57,644 | 3.2M $ | 0.32 % |
| 36 | Harmony Biosciences Holdings Inc | 111,077 | 3.1M $ | 0.31 % |
| 37 | WaVe Life Sciences Ltd | 404,066 | 2.9M $ | 0.29 % |
| 38 | Collegium Pharmaceutical Inc | 88,352 | 2.9M $ | 0.29 % |
| 39 | Nuvation Bio Inc | 668,795 | 2.9M $ | 0.29 % |
| 40 | EyePoint Inc | 217,506 | 2.8M $ | 0.28 % |
| 41 | Xeris Biopharma Holdings Inc | 463,758 | 2.7M $ | 0.27 % |
| 42 | Pacira BioSciences Inc | 114,720 | 2.6M $ | 0.26 % |
| 43 | Rapport Therapeutics Inc | 79,927 | 2.5M $ | 0.25 % |
| 44 | MBX Biosciences Inc | 70,280 | 2.1M $ | 0.21 % |
| 45 | Omeros Corp | 198,165 | 2.1M $ | 0.21 % |
| 46 | Amphastar Pharmaceuticals Inc | 98,895 | 1.9M $ | 0.19 % |
| 47 | Arvinas Inc | 179,506 | 1.9M $ | 0.19 % |
| 48 | Maze Therapeutics Inc | 59,177 | 1.8M $ | 0.18 % |
| 49 | Theravance Biopharma Inc | 103,389 | 1.7M $ | 0.17 % |
| 50 | LB Pharmaceuticals Inc | 67,960 | 1.7M $ | 0.17 % |
| 51 | Phathom Pharmaceuticals Inc | 139,379 | 1.5M $ | 0.15 % |
| 52 | Septerna Inc | 63,823 | 1.5M $ | 0.15 % |
| 53 | BioAge Labs Inc | 84,022 | 1.5M $ | 0.15 % |
| 54 | CorMedix Inc | 204,800 | 1.4M $ | 0.14 % |
| 55 | Evolus Inc | 181,171 | 744.6K $ | 0.07 % |
| 56 | LENZ Therapeutics Inc | 61,219 | 560.2K $ | 0.06 % |
Sector breakdown
- Health care 70.4 %
- Unattributed 29.6 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 95.6 %
- Ireland 3.6 %
- Canada 0.5 %
- Singapore 0.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 52 | 955.2M $ | 95.56 % |
| 2 | Ireland | 2 | 36.2M $ | 3.63 % |
| 3 | Canada | 1 | 5.2M $ | 0.52 % |
| 4 | Singapore | 1 | 2.9M $ | 0.29 % |
Cite this page
Titelia. "Holdings of iShares U.S. Pharmaceuticals ETF". https://titelia.com/en/funds/S000009417